Coronary Artery Disease and Myocardial Infarction

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s
ESC 23 Late-Breaker Discussion: The RECORD MI Registry

Harriette Van Spall, Javed Butler,

Watch time: 9m 37s
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
ESC 23: LODESTAR Trial

Myeong-Ki Hong,

Watch time: 3m 42s

Yan Yan, Gilles Montalescot, Mathieu Kerneis, et al

Watch time: 5h 59m 38s (60 videos)

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s

Heather Currie , Christine Williams ,

Read time: 10m

Edward T Carreras , Donna M Polk ,

FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s

Charles H Hennekens , Danielle Hollar , Arthur S Agatston ,

Sergio Fazio ,

Marc Sirol ,

Abdulah Alrifai , Mohamad Kabach , Jonathan Nieves , et al

Donald E Cutlip ,

Marsha M Neumyer , Bill Bertolino ,

Read time: 11m

Antonio Gutierrez , Sunil V Rao ,

Watch time: 1h 7m 2s (4 videos)

Media

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23 Late-Breaker Discussion: The RECORD MI Registry

Harriette Van Spall, Javed Butler,

Watch time: 9m 37s
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s

Yan Yan, Gilles Montalescot, Mathieu Kerneis, et al

Watch time: 5h 59m 38s (60 videos)

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3m 24s

Media

ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
ESC 23: LODESTAR Trial

Myeong-Ki Hong,

Watch time: 3m 42s
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s

Yan Yan, Gilles Montalescot, Mathieu Kerneis, et al

Watch time: 5h 59m 38s (60 videos)

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)
ESC 23 Late-Breaker Discussion: The RECORD MI Registry

Harriette Van Spall, Javed Butler,

Watch time: 9m 37s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s

Jacqueline Saw,

Watch time: 46m 14s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s

Watch time: 1h 7m 2s (4 videos)
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s

Articles

Coronary CT Angiography-derived FFR

Lavanya Cherukuri

,

Divya Birudaraju

,

Matthew J Budoff

,

Published:

23 April 2021

Citation:

US Cardiology Review 2021;15:e06.

DOI:

https://doi.org/10.15420/usc.2020.24
  • Views: Views 1871
  • Downloads: Downloads 78
  • Citations: 1

Current Evidence and Future Directions of PCSK9 Inhibition

Jiaqian Xu

,

Michael D Shapiro

,

Published:

16 February 2021

Citation:

US Cardiology Review 2021;15:e01.

DOI:

https://doi.org/10.15420/usc.2020.17
  • Views: Views 3300
  • Downloads: Downloads 155

HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick

,

Pratik Sandesara

,

Arshed A Quyyumi

,

Laurence S Sperling

,

Published:

12 March 2019

Citation:

US Cardiology Review 2019;13(1):49–53

DOI:

https://doi.org/10.15420/usc.2019.3.2
  • Views: Views 3386
  • Downloads: Downloads 33
  • Citations: 5

Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease

Michael Megaly

,

Marwan Saad

,

Emmanouil S Brilakis

,

Published:

12 March 2019

Citation:

US Cardiology Review 2019;13(1):16–20

DOI:

https://doi.org/10.15420/usc.2019.4.1
  • Views: Views 1489
  • Downloads: Downloads 40
  • Citations: 4